CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-13 | ATLAS VENTURE ASSOCIATES X, L.P. 10% owner | Other disposition | −1,046,426 | 3,710,052 | ||
| 2020-02-12 | MACKAY GEOFFREY | Sale | −1,400 | $29.07 | $41K | 345,123 |
| 2020-02-11 | PAIGE CHRISTOPHER Director | Sale | −15,000 | $28.00 | $420K | 252,512 |
| 2020-02-11 | MACKAY GEOFFREY | Sale | −44,596 | $27.36 | $1.2M | 364,927 |
| 2020-02-11 | MACKAY GEOFFREY | Sale | −18,404 | $28.10 | $517K | 346,523 |
| 2020-01-28 | PAIGE CHRISTOPHER Director | Sale | −10,000 | $23.00 | $230K | 267,512 |
| 2019-07-19 | Atlas Venture Fund X, L.P. 10% owner | Purchase | +810,811 | $18.50 | $15.0M | 5,567,289 |
| 2019-07-19 | Booth Bruce Director | Purchase | +810,811 | $18.50 | $15.0M | 5,567,289 |
| 2019-06-11 | Vickers Philip J. Director | Grant or award · Stock Option (Right to Buy) | +9,675 | 9,675 | ||
| 2019-06-11 | PAIGE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +9,675 | 9,675 | ||
| 2019-06-11 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +9,675 | 9,675 | ||
| 2019-06-11 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +9,675 | 9,675 | ||
| 2019-06-11 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy | +9,675 | 9,675 | ||
| 2019-06-11 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +9,675 | 9,675 | ||
| 2019-05-20 | Clarus Lifesciences III, L.P. 10% owner | Other disposition | −1,481,163 | 1,481,162 | ||
| 2019-04-08 | PAIGE CHRISTOPHER Director | Sale | −2,400 | $25.84 | $62K | 277,612 |
| 2019-04-08 | PAIGE CHRISTOPHER Director | Sale | −100 | $26.92 | $3K | 277,512 |
| 2019-04-08 | MACKAY GEOFFREY | Sale | −698 | $27.07 | $19K | 409,523 |
| 2019-04-05 | PAIGE CHRISTOPHER Director | Sale | −6,633 | $25.59 | $170K | 280,879 |
| 2019-04-05 | PAIGE CHRISTOPHER Director | Sale | −867 | $26.21 | $23K | 280,012 |
Page 14 of 17 · 322 trades